Cargando…
Combination of retinoids and narrow-band ultraviolet B inhibits matrix metalloproteinase 13 expression in HaCaT keratinocytes and a mouse model of psoriasis
Matrix metalloproteinase13 (MMP13) can be released by keratinocytes and fibroblasts and involved in the pathogenesis of skin disorders. Retinoic acid derivative drugs include tazarotene and acitretin. Tazarotene/acitretin and narrow-band ultraviolet B (NB-UVB) irradiation are common treatment option...
Autores principales: | Xi, Chan, Xiong, Chuanxi, Wang, Huiping, Liu, Yuanjun, Luo, Suju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233442/ https://www.ncbi.nlm.nih.gov/pubmed/34172768 http://dx.doi.org/10.1038/s41598-021-92599-w |
Ejemplares similares
-
Activation of matrix metalloproteinases and FoxO3a in HaCaT keratinocytes by radiofrequency electromagnetic field exposure
por: Kim, Ju Hwan, et al.
Publicado: (2021) -
Melanoma stimulates the proteolytic activity of HaCaT keratinocytes
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022) -
Horse Oil Mitigates Oxidative Damage to Human HaCaT Keratinocytes Caused by Ultraviolet B Irradiation
por: Piao, Mei Jing, et al.
Publicado: (2019) -
Protein dataset of immortalized keratinocyte HaCaT cells and normal human keratinocytes
por: Rusanov, A.L., et al.
Publicado: (2021) -
Cytotoxicity patterns of arsenic trioxide exposure on HaCaT keratinocytes
por: Udensi, Udensi K, et al.
Publicado: (2011)